Browsing: Mirae

NEW YORK, July 28, 2026 /PRNewswire/ — Mirae, an AI-driven continuous care platform for autoimmune disease and other complex chronic conditions, today announced $5.4 million in funding led by Oxford Science Enterprises. Mirae captures what patients experience between visits and converts it into acontinuous, structured view of disease that clinicians can act on at the point…